Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection.
Open Access
- 1 August 1998
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 102 (3), 550-560
- https://doi.org/10.1172/jci3065
Abstract
Human invasive soft-tissue infections caused by group A Streptococcus are associated with significant morbidity and mortality. To investigate the pathogenesis of these serious infections, we characterized the host response to bacterial challenge with an M-type 3 isolate recovered from a patient with necrotizing fasciitis, or with isogenic gene replacement mutants deficient in cysteine protease, hyaluronic acid capsule, or M protein in a murine model of human invasive soft-tissue infection. Animals challenged with the wild-type or cysteine protease-deficient strain developed spreading tissue necrosis at the site of inoculation, became bacteremic, and subsequently died. Histopathologic examination of the necrotic lesion revealed bacteria throughout inflamed subcutaneous tissue. Arterioles and venules in the subcutaneous layer were thrombosed and the overlying tissue was infarcted. In contrast, animals challenged with either an acapsular or M protein-deficient mutant developed a focal area of tissue swelling at the site of inoculation without necrosis or subsequent systemic disease. Histopathologic examination of the soft-tissue lesion demonstrated bacteria confined within a well-formed subcutaneous abscess. We conclude that the group A streptococcal hyaluronic acid capsule and M protein, but not the cysteine protease, are critical for the development of tissue necrosis, secondary bacteremia, and lethal infection in a murine model of human necrotizing fasciitis.This publication has 27 references indexed in Scilit:
- Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection.Journal of Clinical Investigation, 1996
- Invasive Group A Streptococcal Infections in Ontario, CanadaNew England Journal of Medicine, 1996
- Recombinant, octavalent group A streptococcal M protein vaccineVaccine, 1996
- Genetic and Phenotypic Diversity among Isolates of Streptococcus pyogenes from Invasive InfectionsThe Journal of Infectious Diseases, 1996
- Molecular Characterization of hasC from an Operon Required for Hyaluronic Acid Synthesis in Group A Streptococci DEMONSTRATION OF UDP-GLUCOSE PYROPHOSPHORYLASE ACTIVITYPublished by Elsevier ,1995
- Streptococcal Cysteine Proteinase Releases Biologically Active Fragments of Streptococcal Surface ProteinsJournal of Biological Chemistry, 1995
- Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice.Proceedings of the National Academy of Sciences, 1994
- Molecular characterization of hasA from an operon required for hyaluronic acid synthesis in group A streptococci.Journal of Biological Chemistry, 1994
- Molecular cloning, identification, and sequence of the hyaluronan synthase gene from group A Streptococcus pyogenes.Journal of Biological Chemistry, 1993
- Geographic and Temporal Distribution and Molecular Characterization of Two Highly Pathogenic Clones ofStreptococcus pyogenesExpressing Allelic Variants of Pyrogenic Exotoxin A (Scarlet Fever Toxin)The Journal of Infectious Diseases, 1993